Tuesday, March 17, 2026

NEVER-ENDING Threat: Kim Jong Un Fires 4 Times In Two Weeks—The Peninsula Is Under Constant Attack

North Korea launched a suspected ballistic missile into the East Sea on November 7, heightening military readiness in the region.

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

LG’s Transparent OLED TV Takes Top Honors at IFA 2025: A Game Changer in Home Entertainment!

LG's transparent OLED TV won Best of IFA at the 2025 Innovation Awards, highlighting its innovative technology and design.

Tag: Dupixent

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.